Bio Solution Co.,Ltd. (KOSDAQ:086820)

Market Cap	209.53B
Revenue (ttm)	8.27B
Net Income (ttm)	-1.28B
Shares Out	23.89M
EPS (ttm)	-53.69
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,447
Average Volume	89,763
Open	8,970.00
Previous Close	8,750.00
Day's Range	8,610.00 - 8,970.00
52-Week Range	4,436.67 - 13,200.00
Beta	0.69
RSI	47.53
Earnings Date	n/a

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 71
• Stock Exchange: KOSDAQ
• Ticker Symbol: 086820